US Pharma MarketingRoche commits $750m to double Oregon-based US manufacturing capacity
Roche commits $750m to double Oregon-based US manufacturing capacity is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio.
Source: Pharmaceutical Technology